Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues
Author(s) -
Robert Paul Thomas,
Mark R. Hellmich,
Courtney M. Townsend,
B. Mark Evers
Publication year - 2003
Publication title -
endocrine reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.357
H-Index - 272
eISSN - 1945-7189
pISSN - 0163-769X
DOI - 10.1210/er.2002-0028
Subject(s) - gastrin , neurotensin , cholecystokinin , hormone , endocrinology , medicine , somatostatin , peptide hormone , receptor , bombesin , secretin , secretion , gastrointestinal hormone , biology , vasoactive intestinal peptide , pancreatic polypeptide , pancreas , motility , neuropeptide , glucagon , microbiology and biotechnology
Gastrointestinal (GI) hormones are chemical messengers that regulate the physiological functions of the intestine and pancreas, including secretion, motility, absorption, and digestion. In addition to these well-defined physiological effects, GI hormones can stimulate proliferation of the nonneoplastic intestinal mucosa and pancreas. Furthermore, in an analogous fashion to breast and prostate cancer, certain GI cancers possess receptors for GI hormones; growth can be altered by administration of these hormones or by blocking their respective receptors. The GI hormones that affect proliferation, either stimulatory or inhibitory, include gastrin, cholecystokinin, gastrin-releasing peptide, neurotensin, peptide YY, glucagon-like peptide-2, and somatostatin. The effects of these peptides on normal and neoplastic GI tissues will be described. Also, future perspectives and potential therapeutic implications will be discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom